We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Top Sells

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$63.6M
2
CMCSA icon
Comcast
CMCSA
+$39.7M
3
EVRG icon
Evergy
EVRG
+$38.5M
4
PEG icon
Public Service Enterprise Group
PEG
+$38.4M
5
TECH icon
Bio-Techne
TECH
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUDC icon
2326
AudioCodes
AUDC
$233M
– –
-9,017
Closed -$243K
AUPH icon
2327
Aurinia Pharmaceuticals
AUPH
$2.21B
– –
-11,336
Closed -$147K
AVB
2328
DELISTED
AvalonBay Communities
AVB
– –
-6,793
Closed -$1.25M
AVNT icon
2329
Avient
AVNT
$4.07B
– –
-10,150
Closed -$480K
AVPT icon
2330
AvePoint
AVPT
$2.82B
– –
-18,334
Closed -$203K
AVXL icon
2331
Anavex Life Sciences
AVXL
$289M
– –
-25,007
Closed -$374K
AWI icon
2332
Armstrong World Industries
AWI
$7.52B
– –
-12,537
Closed -$1.13M
AWR icon
2333
American States Water
AWR
$3.6B
– –
-17,561
Closed -$1.33M
AXON
2334
Axon Enterprise
AXON
$48.9B
– –
-2,092
Closed -$298K
BANC icon
2335
Banc of California
BANC
$2.96B
– –
-32,034
Closed -$579K
BAND
2336
Bandwidth Inc
BAND
$1.49B
– –
-5,123
Closed -$649K
BANR icon
2337
Banner Corp
BANR
$2.42B
– –
-7,424
Closed -$396K
BAP icon
2338
Credicorp
BAP
$30.2B
– –
-6,526
Closed -$891K
BBIO icon
2339
BridgeBio Pharma
BBIO
$15.9B
– –
-10,889
Closed -$671K
BBW icon
2340
Build-A-Bear
BBW
$490M
– –
-47,286
Closed -$326K
BBY icon
2341
Best Buy
BBY
$18.5B
– –
-13,781
Closed -$1.58M
BCO icon
2342
Brink's
BCO
$4.6B
– –
-11,303
Closed -$896K
BCX icon
2343
BlackRock Resources & Commodities Strategy Trust
BCX
$1B
– –
-21,285
Closed -$189K
BEEM icon
2344
Beam Global
BEEM
$32.2M
– –
-25,242
Closed -$1.09M
BEKE icon
2345
KE Holdings
BEKE
$19.6B
– –
-38,605
Closed -$2.2M
BELFA icon
2346
Bel Fuse Inc Class A
BELFA
$2.99B
$0 ﹤0.01%
+2
New +$32
BFAM icon
2347
Bright Horizons
BFAM
$3.62B
– –
-5,025
Closed -$862K
BFLY icon
2348
Butterfly Network
BFLY
$2.37B
– –
-112,743
Closed -$1.9M
BHC icon
2349
PUT
Bausch Health
BHC
$2.46B
– –
-124,200
Closed -$3.94M
BHP icon
2350
BHP
BHP
$246B
– –
-18,878
Closed -$1.17M
92 93
94
95 96

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.